设为首页 加入收藏

TOP

Paclitaxel(Patient Information Included)(二十一)
2013-09-17 20:21:55 来源: 作者: 【 】 浏览:12810次 评论:0
a, vomiting, and/or diarrhea following paclitaxel use.  If you experience nausea or stomach upset, tell your doctor.  Diarrhea will usually disappear without treatment; however, if you experience severe abdominal or stomach area pain and/or severe diarrhea, tell your doctor right away.

   Talk with your doctor or other healthcare professional to discuss ways to prevent or reduce some of these side effects. Because this leaflet does not include all possible side effects that can occur with paclitaxel, it is important to talk to your doctor about other possible side effects.

CAN I TAKE PACLITAXEL IF I AM PREGNANT OR NURSING A BABY?

Paclitaxel could harm the fetus when given to a pregnant woman.  Women should avoid becoming pregnant while they are undergoing treatment with paclitaxel.  Tell your doctor if you become pregnant or plan to become pregnant while taking paclitaxel.

Because studies have shown paclitaxel to be present in the breast milk of animals receiving the drug, it may be present in human breast milk as well.  Therefore, nursing a baby while taking paclitaxel is NOT recommended.

This medicine was prescribed for your particular condition.  This summary does not include everything there is to know about paclitaxel.  Medicines are sometimes prescribed for purposes other than those listed in a Patient Information Leaflet.  If you have questions or concerns, or want more information about paclitaxel, your doctor and pharmacist have the complete prescribing information upon which this guide is based.  You may want to read it and discuss it with your doctor.  Remember, no written summary can replace careful discussion with your doctor.

This Patient Information Leaflet has been approved by the U.S. Food and Drug Administration.

Hospira, Inc.

Lake Forest, IL 60045

Product of Australia

Revision August 2007

483145

483144

483148

483150

PACLITAXEL 
paclitaxel injection, solution 
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61703-342
Route of Administration INTRAVENOUS DEA Schedule      
 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PACLITAXEL (PACLITAXEL)  PACLITAXEL 6 mg  in 1 mL
 
Inactive Ingredients
Ingredient Name Strength
POLYOXYL 35 CASTOR OIL  
ALCOHOL  
CITRIC ACID  
 
Product Characteristics
Color      Score     
Shape  Size 
Flavor  Imprint Code 
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61703-342-09 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
1  5 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-09)
2 NDC:61703-342-22 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
2  16.7 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-22)
3 NDC:61703-342-50 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
3  50 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-50)
Marketing Information 
Marketing Cate

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 18 19 20 21 22 下一页 尾页 21/22/22
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Krystexxa(pegloticase) 下一篇INCIVEK(telaprevir)tablet, film..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位